TSHA — TAYSHA GENE THERAPIES INC

Ownership history in Engineers Gate Manager LP  ·  7 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in TAYSHA GENE THERAPIES INC (TSHA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q1)
Avg. % of fund
0.0%
First filed
2023 Q1
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 53,483 -11,134 -17.2% 0.00% $175K $3.27
2025 Q2 ADDED 64,617 +28,809 +80.5% 0.00% $149K $2.31
2024 Q4 REDUCED 35,808 -75,184 -67.7% 0.00% $62K $1.73
2024 Q1 ADDED 110,992 +89,296 +411.6% 0.01% $319K $2.87
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TSHA price (monthly, adj. close)

Other funds also holding TSHA

As of 2025 Q4 — sorted by position size

B Group, Inc. 7.31% Octagon Capital Advisors LP 3Y 5.92% GordonMD Global Investments LP 5.25% SUPERSTRING CAPITAL MANAGEMENT LP 2.89% Ally Bridge Group (NY) LLC 3Y 2.86% Ally Bridge Group (NY) LLC 3Y 2.62% Vestal Point Capital, LP 2.57% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 1.7% Siren, L.L.C. 1.66% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.33%
← Back to Engineers Gate Manager LP Holdings